AG8 Stock Overview
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Agilent Technologies, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$134.00 |
52 Week High | US$136.65 |
52 Week Low | US$94.96 |
Beta | 1.11 |
1 Month Change | 10.24% |
3 Month Change | 6.82% |
1 Year Change | 8.87% |
3 Year Change | 26.25% |
5 Year Change | 87.57% |
Change since IPO | 527.49% |
Recent News & Updates
Recent updates
Shareholder Returns
AG8 | DE Life Sciences | DE Market | |
---|---|---|---|
7D | -0.6% | 4.1% | 1.6% |
1Y | 8.9% | -5.0% | 6.4% |
Return vs Industry: AG8 exceeded the German Life Sciences industry which returned -3.7% over the past year.
Return vs Market: AG8 exceeded the German Market which returned 6.4% over the past year.
Price Volatility
AG8 volatility | |
---|---|
AG8 Average Weekly Movement | 3.5% |
Life Sciences Industry Average Movement | 6.2% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: AG8 has not had significant price volatility in the past 3 months.
Volatility Over Time: AG8's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 17,700 | Mike McMullen | https://www.agilent.com |
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Agilent Technologies, Inc. Fundamentals Summary
AG8 fundamental statistics | |
---|---|
Market cap | €39.87b |
Earnings (TTM) | €1.14b |
Revenue (TTM) | €6.21b |
34.5x
P/E Ratio6.3x
P/S RatioIs AG8 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AG8 income statement (TTM) | |
---|---|
Revenue | US$6.74b |
Cost of Revenue | US$3.33b |
Gross Profit | US$3.41b |
Other Expenses | US$2.17b |
Earnings | US$1.24b |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 4.22 |
Gross Margin | 50.56% |
Net Profit Margin | 18.35% |
Debt/Equity Ratio | 41.3% |
How did AG8 perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield22%
Payout RatioDoes AG8 pay a reliable dividends?
See AG8 dividend history and benchmarksAgilent Technologies dividend dates | |
---|---|
Ex Dividend Date | Apr 01 2024 |
Dividend Pay Date | Apr 24 2024 |
Days until Ex dividend | 5 days |
Days until Dividend pay date | 28 days |
Does AG8 pay a reliable dividends?
See AG8 dividend history and benchmarks